BioSpace News Archive

Business

Cypralis and Gilead Agree on License Terms Under Which Cypralis Will Hold Exclusive Development and Commercialization Rights to Certain Jointly-Owned ‘Cyprolides’ for Acute and Chronic Degenerative Diseases

Cypralis and Gilead Sciences have agreed that Cypralis will have exclusive development and commercialization rights to certain macrocyclic inhibitors of peptide bond isomerases, in all fields except for oncology and virology.

January 8, 2018
·
1 min read
Business

Sanifit Announces the Appointment of Cris Calsada as CFO

Ms. Calsada joins Sanifit with over 20 years of corporate finance and executive experience in the life sciences and technology industries.

January 8, 2018
·
2 min read
Business

TG Therapeutics and Jiangsu Hengrui Medicine Announce Global License Agreement for Development and Commercialization of Novel BTK Inhibitor Program for the Treatment of Hematologic Malignancies

In addition to TG-1701, the global license agreement covers TG-1702 (SHR-1266), another BTK inhibitor in pre-clinical development.

January 8, 2018
·
7 min read
BioMidwest

KemPharm Initiates Pivotal Efficacy Trial of KP415

The trial is designed to support a potential label for KP415 for both an early onset and long duration of a KP415 treatment effect in ADHD patients.

January 8, 2018
·
5 min read
Drug Development

Mateon Announces New Preclinical Data Demonstrating Enhanced Tumor Immune Responses when CA4P is Given in Combination With Checkpoint Inhibitors

The new findings show that treatment with the combination of CA4P and an anti-CTLA-4 antibody nearly doubles the amount of tumor necrosis.

January 8, 2018
·
4 min read
Deals

Zymergen Acquires Metagenomics Company Radiant Genomics

Zymergen today announced the acquisition of Radiant Genomics, a leader in functional metagenomics research.

January 8, 2018
·
3 min read
Biotech Beach

AntiCancer Inc. Has Developed a Methuselah Enzyme Taken Orally That Hopefully Extends Normal Lifespan and Also Arrests Cancer

The common amino-acid methionine, present in all proteins, is a culprit in the aging process as well as in cancer.

January 8, 2018
·
2 min read
Juvenescence Closes Seed Round With Participation From Seasoned Biotech Investors

Juvenescence announced that it has closed its seed funding round, raising US $12.3 million.

January 8, 2018
·
3 min read
Drug Development

CymaBay Therapeutics: Enrollment Begins in Long-Term Extension Study of Seladelpar in Patients With Primary Biliary Cholangitis

The objectives of the study are to provide additional long-term safety and efficacy data that will support the seladelpar registration program and to follow patients until registration of seladelpar.

January 8, 2018
·
5 min read
Drug Development

NewLink Genetics Outlines 2018 Business Priorities to Support Phase III Pivotal Trial of Indoximod Plus PD-1 Inhibitors

In addition, the company updated clinical and financial guidance and provided preliminary unaudited financial information for year-end 2017.

January 8, 2018
·
5 min read